Literature DB >> 24605149

Secondary amine-initiated three-component synthesis of 3,4-dihydropyrimidinones and thiones involving alkynes, aldehydes and thiourea/urea.

Jie-Ping Wan1, Yunfang Lin1, Kaikai Hu1, Yunyun Liu1.   

Abstract

The three-component reactions of aldehydes, electron deficient alkynes and ureas/thioureas have been smoothly performed to yield a class of unprecedented 3,4-dihydropyrimidinones and thiones (DHPMs). The reactions are initiated by the key transformation of an enamine-type activation involving the addition of a secondary amine to an alkyne, which enables the subsequent incorporation of aldehydes and ureas/thioureas. This protocol tolerates a broad range of aryl- or alkylaldehydes, N-substituted and unsubstituted ureas/thioureas and alkynes to yield the corresponding DHPMs with specific regioselectivity.

Entities:  

Keywords:  DHPMs; alkynes; diversity; enamine activation; multicomponent reactions

Year:  2014        PMID: 24605149      PMCID: PMC3943560          DOI: 10.3762/bjoc.10.25

Source DB:  PubMed          Journal:  Beilstein J Org Chem        ISSN: 1860-5397            Impact factor:   2.883


Introduction

DHPMs are well-known heterocyclic scaffolds with abundant biological relevance [1-3]. The DHPM backbone has been found in a class of marine natural products possessing anti-HIV activity [4]. What’s more, diversified other biological activities have been discovered in many synthesized small DHPMs. For example, monastrol (A) [5], (R)-SQ 32926 (B) [6] and (+)-SNAP-7941(C) [7] are lead compounds possessing outstanding antitumor, antihypertensive and melanin-concentrating hormone receptor antagonism activities, respectively (Figure 1).
Figure 1

Some DHPMs-based lead compounds.

Some DHPMs-based lead compounds. More recently, it was shown that DHPMs display many new bioactivities such as antioxidation [8], antibacterial [9], antimalaria [10], antimicrobial [11] and sodium iodide symporter inhibition [12], suggesting the great potential of DHPMs in discovering new lead compounds and medicines. Besides their attractiveness in biological and medicinal researches, DHPMs have also been demonstrated as quite flexible precursors for the synthesis of many other derived heterocyclic scaffolds [13]. For a rather long period, the Biginelli reaction involving the condensation of aldehydes, β-ketoesters and ureas (thioureas) [14] has been dominantly employed for DHPMs synthesis in both racemic [15-18] and asymmetric versions [19-23]. Despite of many recognized advantages of the Biginelli reaction, the product diversity suffered from limitations because β-ketoesters or 1,3-diketones are intrinsically required as donors of the C5–C6 fragment in this reaction, which predetermined the presence of a C6 substitution in the produced DHPMs. On the other hand, DHPMs without a substituent at the C6 site were hardly accessible by the classical Biginelli reaction, probably because of either the rare availability of the corresponding β-formylketone/ester substrates or the intolerance of β-formylketones/esters in the Biginelli reaction. In regard to the daily increasing requirements on molecular diversity, developing powerful methods for the rapid synthesis of DHPMs with diverse and unprecedented substitution patterns has become an issue of central importance. During the last decade, tremendous endeavours have been made to devise efficient synthetic routes to access structurally diverse DHPMs by employing multicomponent reactions (MCRs) [24-26]. Interestingly, in the process of designing new MCRs yielding DHPMs, the utilization of new C5–C6 fragment donors constituted the major strategy. Representative new C5–C6 building blocks used in the multicomponent synthesis of DHPMs are 2-oxosuccinic acid [27], acetylaldehydes [28], cyclic and acyclic ketones [29-31], β-oxo dithioesters [32], diketenes [33] and enaminones [34]. On the other hand, as frequently utilized building blocks in organic synthesis, alkynes have been known to possess versatile reactivity in the synthesis of small molecules. For example, a previous protocol employing aryl alkynes, aldehydes and urea/thiourea has been found to selectively provide various 1,3-thiazine derivatives 4 [35]. Amazingly, a generally applicable alkyne-based method regioselectively yielding DHPMs has not yet been achieved [36]. Herein, we report the regioselective three-component synthesis of DHPMs employing alkynes, aldehydes and ureas/thioureas by making use of the activation effect of a secondary amine to alkynes (Scheme 1) [37].
Scheme 1

Regioselective 1,3-thiazines and DHPMs via aldehydes, ureas/thioureas and alkynes.

Regioselective 1,3-thiazines and DHPMs via aldehydes, ureas/thioureas and alkynes.

Results and Discussion

The work began from the three-component model reaction of p-chlorobenzaldehyde (1a), thiourea (2a) and ethyl propiolate (3a). The optimization results are outlined in Table 1. Firstly, parallel studies respectively employing TMSCl, morpholine and mixed TMSCl/morpholine as catalysts have been conducted. It was found that the target product could be formed only when both morpholine and TMSCl were present (Table 1, entries 1–3). Extended experiments using different amounts and types of amine catalysts demonstrated that 0.5 equiv of piperazine was favorable (Table 1, entries 4–6). Reducing the amount of TMSCl led to a decrease in product yield (Table 1, entry 7). Other Lewis acid or Brønsted acids such as FeCl3 and p-TSA gave no better result for the same reaction (Table 1, entries 8 and 9). In addition, the non-polar solvent toluene was not able to mediate the reaction, while a lower yield of product was observed when MeCN was used as solvent (Table 1, entries 10 and 11). Altering the reaction temperature also failed to enhance the yield (Table 1, entries 12 and 13). Finally, employing additional 0.5 equiv of p-TSA has been found to significantly improve the yield (Table 1, entry 14). This result may be attributed to the double activation effect involving both Lewis and Brønsted acid (see Scheme 3).
Table 1

Optimization of reaction conditionsa.


EntryCatalystsSolventT (°C)Yield (%)b

1morpholine/TMSClDMF9045
2cTMSClDMF90nr
3cmorpholineDMF90nr
4dmorpholine/TMSClDMF9025
5pyrrolidine/TMSClDMF9013
6piperazine/TMSClDMF9059
7epiperazine/TMSClDMF9040
8piperazine/FeCl3DMF90nr
9piperazine/p-TSADMF9015
10piperazine/TMSClCH3CN9039
11piperazine/TMSCltoluene90nr
12piperazine/TMSClDMF8027
13piperazine/TMSClDMF10039
14fpiperazine/TMSClDMF9081

aGeneral conditions: 1a (0.3 mmol), 2a (0.4 mmol), 3a (0.3 mmol), secondary amine (0.15 mmol) and acid (0.6 mmol) in 4 mL solvent, stirred for 12 h. bYields of isolated product. cNo reaction. d0.09 mmol (30 mol %) morpholine was used. e0.45 mmol TMSCl was used. fAdditional 0.5 equiv of p-TSA was used.

Scheme 3

Proposed reaction mechanism.

Optimization of reaction conditionsa. aGeneral conditions: 1a (0.3 mmol), 2a (0.4 mmol), 3a (0.3 mmol), secondary amine (0.15 mmol) and acid (0.6 mmol) in 4 mL solvent, stirred for 12 h. bYields of isolated product. cNo reaction. d0.09 mmol (30 mol %) morpholine was used. e0.45 mmol TMSCl was used. fAdditional 0.5 equiv of p-TSA was used. With the optimal conditions in hand, we conducted the investigation on examining the application scope. Various aldehydes of different properties have been subjected to react with thioureas/N-substituted thioureas/urea as well as different propiolates. Typical results were listed in Table 2. It can be seen from these reactions that aldehydes containing various functional groups tolerate the protocol of the corresponding DHPMs synthesis. For reactions involving aromatic aldehydes, the electronic properties of the substituent exhibited evident impact on the product yield. Aldehydes containing an electron withdrawing group (EWG) facilitated the reactions to give related DHPMs with evidently higher yields than those containing an electron donating group (EDG) (Table 2, products 5a–5e, 5i–5k). A similar tendency occurred in the experiments using N-methyl thiourea (Table 2, products 5f–5h). Attempts on employing EDG-substituted aldehydes such as p-tolylaldehyde to react with N-substituted thiourea and alkyne were not successful. On the other hand, benzaldehydes with ortho- and meta-substitution could also react with thioureas and propiolates to give the corresponding DHPMs 5l–5p. However, compared with thiourea, urea has been found to undergo a similar transformation more toughly, and DHPMs 5q–5s from urea reactions have been obtained with only moderate yields under the conditions of refluxing THF (Table 2, products 5q–5s). Notably, this synthetic methodology displayed also good tolerance to aliphatic aldehydes to provide 4-alkyl DHPMs 5t–5v with good to excellent yield (Table 2).
Table 2

Multicomponent synthesis of different DHPMs.a


R1R2R3XProductYield (%)b

4-ClC6H4HEtS5a81
4-BrC6H4HEtS5b70
4-CF3C6H4HEtS5c72
4-NO2C6H4HEtS5d85
4-MeC6H4HEtS5e58
4-ClC6H4MeEtS5f78
4-BrC6H4MeEtS5g63
4-CF3C6H4MeEtS5h83
4-ClC6H4HMeS5i72
4-CF3C6H4HMeS5j81
4-MeC6H4HMeS5k66
3-OHCC6H4HEtS5l68
3-MeOC6H4HEtS5m61
2,4-Cl2C6H3HEtS5n64
2-ClC6H4MeEtS5o75
2-ClC6H4HMeS5p60
4-ClC6H4HEtO5qc43
4-BrC6H4HEtO5rc55
4-NO2C6H4HEtO5sc47
EtHEtS5t82
PrHEtS5u68
PhCH2HEtS5v81

aGeneral conditions: 1 (0.3 mmol), 2 (0.4 mmol), 3 (0.3 mmol), piperazine (0.15 mmol), TMSCl (0.6 mmol), p-TSA (0.15 mmol) in 4 mL DMF, stirred at 90 °C for 12 h. bYield of isolated product. cReactions in refluxing THF, piperazine (0.15 mmol), TMSCl (0.9 mmol) and p-TSA (0.3 mmol).

Multicomponent synthesis of different DHPMs.a aGeneral conditions: 1 (0.3 mmol), 2 (0.4 mmol), 3 (0.3 mmol), piperazine (0.15 mmol), TMSCl (0.6 mmol), p-TSA (0.15 mmol) in 4 mL DMF, stirred at 90 °C for 12 h. bYield of isolated product. cReactions in refluxing THF, piperazine (0.15 mmol), TMSCl (0.9 mmol) and p-TSA (0.3 mmol). Following these obtained results, especially the key function of the secondary amine to activate electron deficient alkynes [34] we conducted the control experiments on both the synthesis of the possible enamino ester and its transformation to the corresponding DHPM product. The results proved that enamino ester 6a could be easily generated and efficiently transformed to target product 5a under standard conditions (without using secondary amine, Scheme 2).
Scheme 2

Synthesis of enamino ester intermediate and its transformation to DHPM.

Synthesis of enamino ester intermediate and its transformation to DHPM. Based on the results from the control experiments, we postulate the reaction mechanism: At first, the addition of the secondary amine to the propiolate gives enamino ester intermediate 6. On the other hand, ureas/thioureas were known to be readily activated by TMSCl to give intermediate 10 [38-39]. Intermediate 10 consequently condenses with the aldehyde which was activated by p-TSA to generate imine 7. The combination of 6 and 7 allows the production of iminium ion 8. Finally, an intramolecular cyclization of 8 leads to the formation of 9 which subsequently undergoes deaminative elimination to result product 5 by releasing the amine catalyst for further recycling (Scheme 3). Proposed reaction mechanism.

Conclusion

In conclusion, we have established an unprecedented amine-initiated three-component protocol for the synthesis of new DHPMs wherein readily available alkynes served as C5–C6 building blocks. This methodology displayed general applicability for aryl- and alkylaldehydes, urea, thiourea, N-substituted thiourea and different alkyl propiolates. The method is useful for the synthesis of diverse new DHPMs which were hardly accessible through known methods such as the Biginelli reaction.

Experimental

General information

All reagents were obtained from commercial sources and used directly without further purification, solvents have been treated following standard processes prior to use. 1H and 13C NMR spectra were recorded on a 400 MHz or 600 MHz apparatus. The frequencies for 1H NMR and 13C NMR experiments are 400 MHz/600 MHz and 100 MHz/150 MHz, respectively. The chemical shifts were reported in ppm employing TMS as internal standard. Melting points were measured with an X-4A instrument without correcting the temperature, IR spectra were measured in KBr on a Spectrum One apparatus and the HRMS were obtained under ESI mode in a Bruker 7-tesla FT-ICR MS instrument.

General procedure for the three-component synthesis of DHPMs 5

Aldehyde 1 (0.3 mmol), urea/thiourea 2 (0.4 mmol) and alkyl propionate 3 (0.3 mmol) piperazine (0.15 mmol), and p-tolylsulfonic acid (0.15 mmol, 0.3 mmol for the reaction of urea) were charged in a 25 mL round bottom flask equipped with a stirring bar. DMF (THF for the reaction of urea) (4 mL) and TMSCl (0.6 mmol, 0.9 mmol for the reaction of urea) were added and the mixture was stirred at 90 °C for 12 h (TLC). After cooling down to room temperature, 5 mL water was added, and the resulting mixture was extracted with ethyl acetate (3 × 8 mL). The organic layers were combined and dried overnight with anhydrous MgSO4. After filtration and removing of the solvent under reduced pressure, the residue was subjected to flash column chromatography to provide pure products. Synthesis of intermediate 6a. Into a 25 mL round bottom flask was added ethyl propiolate (0.6 mmol) and piperazine (0.3 mmol). 1.5 mL DMF was added and the mixture was stirred at rt for 8 h (TLC). Upon completion, 10 mL water was added and the resulting mixture was extracted with EtOAc (3 × 10 mL). The combined organic layer was dried with anhydrous Na2SO4. After removing of the solid by filtration and evaporation of the solvent the product 6a was isolated as white solid. Experimental details on the synthesis of all DHPMs 5 and intermediate 6a, full characterization data as well as 1H and 13C NMR spectra of all products 5 and 6a.
  26 in total

1.  A new substrate for the Biginelli cyclocondensation: direct preparation of 5-unsubstituted 3,4-dihydropyrimidin-2(1H)-ones from a beta-keto carboxylic acid

Authors: 
Journal:  J Org Chem       Date:  2000-10-06       Impact factor: 4.354

2.  A novel four-component reaction for the synthesis of functionalised dihydropyrimidines.

Authors:  Danielle J Vugts; Helen Jansen; Rob F Schmitz; Frans J J de Kanter; Romano V A Orru
Journal:  Chem Commun (Camb)       Date:  2003-10-21       Impact factor: 6.222

Review 3.  Recent advance in the pharmacology of dihydropyrimidinone.

Authors:  J-P Wan; Y Pan
Journal:  Mini Rev Med Chem       Date:  2012-04       Impact factor: 3.862

Review 4.  Asymmetric enamine catalysis.

Authors:  Santanu Mukherjee; Jung Woon Yang; Sebastian Hoffmann; Benjamin List
Journal:  Chem Rev       Date:  2007-12       Impact factor: 60.622

Review 5.  Genesis of dihydropyrimidinone(psi) calcium channel blockers: recent progress in structure-activity relationships and other effects.

Authors:  K Singh; D Arora; K Singh; S Singh
Journal:  Mini Rev Med Chem       Date:  2009-01       Impact factor: 3.862

6.  Reversed chloroquines based on the 3,4-dihydropyrimidin-2(1H)-one scaffold: synthesis and evaluation for antimalarial, beta-haematin inhibition, and cytotoxic activity.

Authors:  Natasha October; Nicholas D Watermeyer; Vanessa Yardley; Timothy J Egan; Kanyile Ncokazi; Kelly Chibale
Journal:  ChemMedChem       Date:  2008-11       Impact factor: 3.466

7.  A novel three-component one-pot reaction involving alkynes, urea or thiourea, and aldehydes.

Authors:  Shenlin Huang; Yuanjiang Pan; Yulin Zhu; Anxin Wu
Journal:  Org Lett       Date:  2005-08-18       Impact factor: 6.005

8.  Highly enantioselective organocatalytic Biginelli reaction.

Authors:  Xiao-Hua Chen; Xiao-Ying Xu; Hua Liu; Lin-Feng Cun; Liu-Zhu Gong
Journal:  J Am Chem Soc       Date:  2006-11-22       Impact factor: 15.419

9.  Chemo-/regioselective synthesis of 6-unsubstituted dihydropyrimidinones, 1,3-thiazines and chromones via novel variants of Biginelli reaction.

Authors:  Jie-Ping Wan; Yuan-Jiang Pan
Journal:  Chem Commun (Camb)       Date:  2009-03-30       Impact factor: 6.222

10.  Synthesis and in vitro microbiological evaluation of novel 4-aryl-5-isopropoxycarbonyl-6-methyl-3,4-dihydropyrimidinones.

Authors:  S Chitra; D Devanathan; K Pandiarajan
Journal:  Eur J Med Chem       Date:  2009-09-16       Impact factor: 6.514

View more
  1 in total

Review 1.  Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions.

Authors:  Francisco Sánchez-Sancho; Marcos Escolano; Daniel Gaviña; Aurelio G Csáky; María Sánchez-Roselló; Santiago Díaz-Oltra; Carlos Del Pozo
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.